|Bid||126.27 x 1100|
|Ask||126.40 x 1000|
|Day's range||126.21 - 129.04|
|52-week range||126.21 - 165.35|
|Beta (5Y monthly)||0.39|
|PE ratio (TTM)||23.21|
|Earnings date||19 Oct 2022|
|Forward dividend & yield||3.65 (2.63%)|
|Ex-dividend date||21 Jul 2022|
|1y target est||158.61|
Procter & Gamble (PG) closed the most recent trading day at $126.25, moving -1.9% from the previous trading session.
If you're not familiar with Vertex Pharmaceuticals (NASDAQ: VRTX), this healthcare stock is certainly one to put on your radar. The company develops and manufactures medicines that treat rare diseases. As of right now, it has four approved products, and all of them treat cystic fibrosis.
It hasn't been the best quarter for The Procter & Gamble Company ( NYSE:PG ) shareholders, since the share price has...